新生儿呼吸衰竭是临床新生儿科经常遇到的危重症。随着各型新式呼吸器的研制成功和通气方法的改进,急性呼吸衰竭救治成功率有较大提高,但新生儿呼吸衰竭的健康成活率仍较低。自1999年3月至2001年1月,我科应用纳洛酮(Naloxone)治疗新生儿呼吸衰竭,取得了良好效果。1 临床资料1.1 一般资料 1999年3月至2001年1月间我科住院新生儿88例,男62例,女26例。入院年龄为出生后20分钟至22天。平均4±1.3天。早产儿28例,足月儿56例,过期产儿4 Neonatal respiratory failure is a critically ill condition often encountered in clinical neonatology. With the successful development of various new respirators and the improvement of ventilation methods, the successful treatment rate of acute respiratory failure has been greatly improved, but the healthy survival rate of neonatal respiratory failure is still low. From March 1999 to January 2001, our department applied Naloxone to treat neonatal respiratory failure and achieved good results. 1 Clinical data 1.1 General Information March 1999 to January 2001 during our hospital inpatient 88 newborns, 62 males and 26 females. Admission age of 20 minutes to 22 days after birth. Average 4 ± 1.3 days. 28 cases of premature children, 56 cases of full-term children, 4 obese children